Representatives of Brussels-based offices leading the work of Health Working Group.
ERRIN’s Health Working Group (WG) supports members with early intelligence and regular updates about EU-level health policy-related issues, regulations, EU programmes and their funding opportunities. Creating opportunities for interregional cooperation in the Health area is one of the WG’s main objectives. The WG is also a vehicle for networking, profile raising and promoting good practices and projects among health stakeholders in the ERRIN regions.
The topic of widening gathers high attention in the discussions around the next European Framework Programme for R&I, raising questions with the potential to influence not only the Widening sub-
The Health Working Group meeting will update colleagues on the European Commission’s initiatives linked to staff and skills shortages and training and up-skilling of the health workforce, exploring
ERRIN has been closely involved in the design and implementation of the EU Missions since their inception. Missions remain one of the network's priorities and were one of the four main areas of focus
The Health Working Group's final meeting of 2020 will be a chance to learn more about and contribute to the WG's plans for 2021.
The 2020 edition of the EHTEL symposium will be a chance to further develop the Imagining 2029 work programme.
This SAPHIRe workshop will help participants gain a better understanding of the regional perspective in the task of making health data accessible.
The UNaLab project, in which ERRIN is a partner, is together with the Grow Green, Connecting Nature and CLEVER Cities projects organising a webinar focusing on the importance of urban green and blue spaces for mental health in light of the current COVID-19 pandemic.
To start planning the activities in the WGs for 2021, the WG leaders will meet according to the clusters to discuss the policy context, project development, and possible topics for the year ahead. All members are warmly invited to provide input in advance.
Considering gender in medical care, demographics and digital society, this event will raise awareness about gender dimensions in the research process.
The ERRIN Year in review 2022 is out! Read the report to see the numerous activities ERRIN and its members have been involved in throughout the year.
Please find attached ERRIN and the network of European Regional and Local Health Authorities (EUREGHA)'s joint statement on the Horizon Europe Mission on Cancer.
Further to the Health WG meeting on the Cancer Mission, EUREGHA and ERRIN have decided to address the Cancer Mission Board with a statement to emphasise the role of regions in this mission.
ERRIN is excited to announce the launch of its new Project Development Tool, a significant game-changer in how ERRIN members and their stakeholders engage in project development activities. We encourage all members to log in, explore this tool and leverage it for their project development needs.
Every year ERRIN defines workstreams to guide its work throughout the year, closely linking to its core missions and priorities, as well as the key initiatives in the EU R&I agenda. Discover what has been planned for 2024 in ERRIN Working Groups and Task Forces.
With the Commission proposal on the next EU Framework Programme for R&I (FP10) expected in mid-2025, this year will be key for setting the tone for further work on the topic and actively engaging in discussion. Have a look at an overview of ERRIN activities currently in the pipeline and opportunities to engage.
General Directorate of Social Assistance and Child Protection (Bacau/Romania) is looking for a partner to form a consortium with in order to apply for the Small Scale Partnership in Youth under Erasmus+. The project will include exchanges of experience between specialists from DGASPC Bacau and a more advanced partner to learn from international experts in the field of developing daily living skills for children with disabilities.
A new Mission Data Platform has recently been launched by TRAMI, the EU-funded project focusing on transnational cooperation on the Mission-approach and effective implementation of the EU Missions. This tool supports and links with ERRIN's work on multi-level governance in the Cities Mission within the NetZeroCities project.
The project aims at developing biomolecules targeting the entry step of arboviruses, through an integrated research approach including virology, molecular virology, protein engineering, structural study (Xtallography and EM), in vitro screening and in vivo validation.
In view of the submission of a European project, Aix-Marseille University (as coordinator) is looking for a SME based in an European Member State (except France) operating in the field of bio-medicine.
ERRIN has submitted its messages in response to the European Commission's call for evidence for the Horizon Europe programme interim evaluation.
ERRIN is looking for a new trainee! The Communications Assistant will have the opportunity to participate in the daily work of the organisation by carrying out communications and member related tasks, as well as supporting daily office activities. The deadline to apply is 10 August.
The guidance on new opportunities to maximise the synergies between Horizon Europe and the European Regional Development Fund (ERDF) programmes was published by the European Commission on 5 July 2022. The document intends to provide a practical and user-friendly approach.
ERRIN is looking for a Climate Neutral Cities Advisor to join its Secretariat! The successful candidate will work to ensure the delivery of the Horizon Europe Mission on Climate-Neutral and Smart Cities by taking part in the activities of the NetZeroCities project. The deadline to apply is 29 July.
On 5 July, the European Commission adopted the new European Innovation Agenda with the aim of positioning Europe at the forefront of the new wave of deep tech innovation and start-ups. The document, to which ERRIN submitted input in May this year, sets out 25 dedicated actions under five flagships, including on European Innovation Ecosystems.